INSIGHTS ON LIQUID DOSE MANUFACTURING
-
What Your Biological Indicator Strategy Might Be Missing
While biological indicators have long been the industry standard for evaluating bio-decontamination cycles, faster, cheaper, and quantifiable contamination detection technologies are emerging.
-
A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies
EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.
-
How Do We Reduce Your Environmental Cost Of Ownership (ECO)?
By rethinking cleanroom requirements and reducing resource-heavy sterilization steps, manufacturers can significantly lower their Environmental Cost of Ownership and futureproof their operations.
-
Isolators For Pharmacy Compounding – Time For Change?
Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.
-
Accountability For The Whole PFS System5/21/2026
When component suppliers only own their part, system-level performance becomes your responsibility. And if something fails, accountability disappears into the gaps.
-
USP <788> Revisions And Why Packaging Matters More Than Ever5/12/2026
Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.
-
Enzyme Indicator Technology5/13/2026
Watch this video to learn how enzyme indicators provide real-time, quantitative data to optimize bio-decontamination and accelerate validation.
-
Comparing Sterility Testing Techniques10/21/2024
Is your sterility testing process hindering your product release? Discover how the right approach can streamline your process, reduce false positives, and ultimately save you time and money.
-
Redefining Prefillable Syringe System5/21/2026
See how our Synchrony S1 pre-fillable syringe system delivers an integrated, system-level solution designed for performance, quality, and scalability — with simplified submissions, synchronized supply, and compatibility across the drug delivery ecosystem.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Successful commercialization takes more than development alone. Explore the manufacturing, quality, and supply chain strategies that support speed, compliance, and supply.
-
Nunc EasyFill Cell Factory system, with its versatile port design, accommodates both pouring and aseptic filling techniques. The design features both a large, easy-to-fill 33mm vented screw closure and a traditional plug 'n' play port, eliminating the need for additional accessories. It is truly an “out-of-the-box” solution or both research and commercial scale cell culture applications.
- Versatile port design for pouring and aseptic filling techniques
- “Out of the box” solution – no additional accessories required
- Traditional Cell Factory features:
- Space saving format: One 10-layer EasyFill Cell Factory equals 36 x T-175 flasks
- Linearly scalable from research to commercial scale applications
- Reduces the risk of contamination (less interactions vs. flasks and roller bottles)
- Nunclon Delta certified ensures performance consistency from lot to lot
-
We are the exclusive manufacturing partner for this innovative auto-injector platform.
-
Open RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved by a barrier (oRABS housing with gloves) between the operator and the product.
-
Process stability, high efficiency and customizable features are crucial issues related to glass packaging manufacturing. Our ampoule forming line perfectly matches these needs, guaranteeing the highest performance thanks to cutting-edge capabilities, such as its automatic inspection system and electric rotational oven, which provides higher product handling stability.